FROM Alan Blinder
Time for a Woman Fed Chairman or Is Banking Still a Man's World? Ben Bernanke's term as Chair of the Federal Reserve won't end until January, but the campaign over who should replace him is already hot and heavy. Larry Summers and Janet Yellen are the leading candidates to replace Bernanke. It's a highly technical job of global importance, but the campaign between their supporters has raised issues of a different kind. New York Times columnist Maureen Dowd has written that Summers "is being pushed by the boys' club around President Obama." Is Yellen as well qualified as Summers? Is it time for a woman, or is big-time banking still a man's world? Is the gender issue relevant to a technical job of global importance?
Trump plays scolder-in-chief with NATO allies At the opening of NATO’s dramatic new headquarters in Brussels today, President Trump acknowledged that Article 5 — promising that “an attack on one nation is an attack on all” -- has only been invoked one time: in the aftermath of September 11. But the President failed to provide what 27 other Alliance members have been waiting for: a re-commitment by America’s new leader to Article 5. Instead, they got a scolding.
Ex-FBI Director Comey tells his side of the story Today, former FBI Director James Comey came close to calling the President who fired him a liar. The White House denied the claim and called it insulting, but Republican Senators did not challenge Comey’s truthfulness. Many questions remain: did the President try to obstruct a federal investigation? Later, we’ll go behind the “velvet rope” for a look at 5-Star health care for the richest Americans.
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.
Replacing Obamacare: Now you see it… now you don’t As the Senate deliberates replacing Obmacare, health coverage for millions of people is at stake. There've been no public hearings, and a draft measure won't be made public. Is the House version so unpopular that that Senate is hiding a version that looks much the same?